tiprankstipranks
Trending News
More News >
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market

Prescient Therapeutics Limited (PTX) Income Statement

Compare
16 Followers

Prescient Therapeutics Limited Income Statement

Last quarter (Q4 2025), Prescient Therapeutics Limited's total revenue was AU$3.11M, an increase of 164.73% from the same quarter last year. In Q4, Prescient Therapeutics Limited's net income was AU$-4.87M. See Prescient Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19M
Gross Profit
AU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89MAU$ 1.19M
Operating Expenses
AU$ 11.89MAU$ 10.90MAU$ 9.88MAU$ 7.10MAU$ 5.43M
Depreciation and Amortization
AU$ 717.00AU$ 717.00AU$ 2.09KAU$ 1.40KAU$ 474.00
EBITDA
AU$ -7.54MAU$ -7.19MAU$ -7.46MAU$ -6.86MAU$ -5.32M
Operating Income
AU$ -7.54MAU$ -7.19MAU$ -9.89MAU$ -7.10MAU$ -5.43M
Other Income/Expenses
AU$ 213.23KAU$ -4.76MAU$ 513.36KAU$ 231.08KAU$ 92.81K
Pretax Income
AU$ -7.32MAU$ -11.95MAU$ -9.37MAU$ -6.87MAU$ -4.15M
Net Income
AU$ -7.32MAU$ -8.24MAU$ -7.00MAU$ -5.12MAU$ -4.15M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01
Diluted EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
804.76M 805.36M 727.53M 647.80M 611.80M
Weighted Average Shares Outstanding (Diluted)
805.31M 805.31M 727.53M 647.80M 611.80M
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History